.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,937,333

« Back to Dashboard

Details for Patent: 4,937,333

Title: Method for purifying aminomethylenephosphonic acids for pharmaceutical use
Abstract:High purity ethylenediaminetetra(methylenephosphonic acid) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylenephosphonic acid) are prepared by dissolving the aminomethylenephosphonic acid in an aqueous base, acidifying with a mineral acid at an elevated temperature to precipitate the crystals, maintaining the solution at an elevated temperature for a period of time sufficient to assure crystallization, cooling to a lower temperature and maintaining at that temperature for a time sufficient to precipitate the crystals and filtering the resulting crystals at that temperature, washing the crystals with water and recovering the desired high purity aminophosphonic acid. The ethylenediaminetetra(methylenephosphonic acid) is obtained in a purer state during its synthesis if the crystals are filtered hot without prior cooling.
Inventor(s): Garlich; Joseph R. (Lake Jackson, TX), Simon; Jaime (Angleton, TX), Masterson; Tipton T. (Lake Jackson, TX)
Assignee: The Dow Chemical Company (Midland, MI)
Filing Date:Aug 04, 1989
Application Number:07/389,441
Claims:1. A process for purifying ethylenediaminetetra(methylenephosphonic acid) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylenephosphonic acid) which comprises the steps of: (a) dissolving the aminophosphonic acid in an aqueous base, (b) adding the solution from step (a) to an acid solution maintained at an elevated temperature to reprecipitate the aminophosphonic acid, (c) heating the solution at an elevated temperature for a period of time sufficient to assure that precipitation of the aminophosphonic acid has begun, (d) cooling the solution to a lower temperature and allowing it to remain at that temperature for a period of time sufficient to assure precipitation of the aminophosphonic acid, (e) filtering the aminophosphonic acid crystals at the lower temperature and finally (f) washing the crystals with water.

2. The process of claim 1 wherein the aqueous base is ammonium hydroxide.

3. The process of claim 2 wherein the acid solution in step (b) is a solution of a mineral acid.

4. The process of claim 3 wherein the mineral acid is hydrochloric acid.

5. The process of claim 4 wherein the temperature in step (d) is in the range of from about ambient to about 95.degree. C.

6. The process of claim 1 wherein for the purification of ethylenediaminetetra(methylenephosphonic acid) step (d) is omitted.

7. The process of claim 1 wherein the heating period in step (c) is from about one-half to about three hours.

8. The process of claim 7 wherein the heating period in step (c) is from about one-half to about one hour.

9. The process of claim 7 wherein the time period in step (d) is from about one to about 24 hours.

10. The process of claim 9 wherein the time period in step (d) is from about 12 to about 24 hours.

11. The process of claim 1 wherein the temperature of step (c) is 35.degree.-105.degree. C.

12. The process of claim 11 wherein the temperature is 70.degree.-105.degree. C.

13. The process of claim 1 wherein steps a through f, inclusive, are repeated at least once.

14. In the process for preparing ethylenediaminetetra(methylenephosphonic acid) by reacting ethylenediamine, phosphorous acid, hydrochloric acid and formaldehyde or paraformaldehyde and heating the reaction medium to reflux temperature, the improvement which comprises filtering the product from the reaction medium prior to cooling.

15. The process of claim 14 wherein the filtration is accomplished while the reaction medium is at reflux temperature.

16. The process of claim 14 wherein the ethylenediamine is in the form of the hydrochloride.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc